Young E W
Center for Biomedical Ethics, Stanford University, Palo Alto, Calif 94304.
Arch Otolaryngol Head Neck Surg. 1991 Jul;117(7):769-73. doi: 10.1001/archotol.1991.01870190081017.
There are three levels at which nontreatment decisions for patients with cancers of the head and neck might be made: not doing further diagnostic procedures when the data gained would not make a significant difference to treatment decisions; not continuing aggressive therapy when its benefits are outweighed by the ensuing burdens and harms; and, at the policy level, not providing costly aggressive therapy at all because of the number of patients with unmet, more basic needs. These three levels of nontreatment decisions are discussed in light of ethical theory, briefly introduced. Arguments are made in favor of nontreatment decisions at the two clinical levels mentioned above, but against a policy decision to ration treatment for patients with cancers of the head and neck.
对于头颈部癌症患者,不进行治疗的决策可在三个层面做出:当所获得的数据对治疗决策不会产生重大影响时,不进行进一步的诊断程序;当积极治疗的益处被随之而来的负担和危害超过时,不继续进行积极治疗;以及在政策层面,由于有更多未满足的基本需求的患者数量众多,根本不提供昂贵的积极治疗。根据简要介绍的伦理理论,对这三个层面的不治疗决策进行了讨论。文中提出了支持上述两个临床层面不治疗决策的论据,但反对对头颈部癌症患者进行治疗配给的政策决策。